Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
Nancy Kuntz, MD
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
Maxwell H. Levy, MD
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Gil I. Wolfe MD, FAAN
Challenges in DMD: Understanding the Height Factor
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
John Brandsema, MD
Continuum of Care: Managing DMD in Pediatric and Adult Patients
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
Charles Turck, PharmD, BCPS, BCCCP
Uncovering a Potential Biomarker for Myasthenia Gravis
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.